TITLE

Genzyme division taps McKay Fried

AUTHOR(S)
Gianatasio, David
PUB. DATE
August 1997
SOURCE
Adweek New England Edition;08/11/97, Vol. 34 Issue 32, p2
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Announces the acquisition of an advertising and public relations account by McKay Fried & Partners for the newly formed unit of Genzyme Corp., a biotechnology company in Cambridge, Massachusetts. Background on the account for the Genzyme Tissue Repair's Carticel surgical procedure; Plans for launching Carticel through a nationwide advertising and public relations campaign.
ACCESSION #
9708175757

 

Related Articles

  • McKay Fried wins medical products client after review. Gianataisio, David // Adweek New England Edition;09/22/97, Vol. 34 Issue 38, p5 

    Reports on McKay Fried & Partners' acquisition of the marketing account of surgical blade maker Becton Dickinson AcuteCare. Estimated billings on the account; McKay's other medical clients.

  • The path less costly. Huggett, Brady // Nature Biotechnology;Oct2010, Vol. 28 Issue 10, p1018 

    In this article the author comments on the cases of Genzyme and Genentech, two U.S. biotechnology companies that took opposite approaches when faced with a competitive threat. He discusses the effort made by Genzyme to acquire competitor Novazyme Pharmaceuticals when the company was in financial...

  • Internet chat damages biotechnology stocks. Niiler, Eric // Nature Biotechnology;Oct2000, Vol. 18 Issue 10, p1030 

    Reports on impact of false Internet postings on the financial status of biotechnology companies in the United States. Corporate profile of Ridgefield, New Jersey-based Biomatrix Inc.; Company history of Cambridge, Massachusetts-based Genzyme Corp.

  • Genzyme Kills Deal To Buy Cell Genesys.  // Chemical Market Reporter;12/27/99, Vol. 256 Issue 26, p28 

    Reports that Genzyme General has terminated its definitive agreement to acquire Cell Genesys. Reason for the termination of the agreement; Overview of the agreement between the two biotechnology companies.

  • DATAMONITOR: Genzyme Corporation.  // Genzyme Corporation SWOT Analysis;Jul2009, p1 

    The article presents a company profile for Genzyme Corp., a biotechnology company based in Cambridge, Massachusetts. It specifically offers an overview on the company's business and economic operation, having been regarded as one of the leading biotechnology firm in the world. Key facts about...

  • THE HEART OF IRELAND'S ECONOMIC DEVELOPMENT STRATEGY. Martin, Miche├íl // BioPharm International;Dec2005 Supplement, p8 

    The article discusses the biotech sector of Ireland. In recent years, Ireland has attracted major biotech players including Genzyme Corp. and Centocor, Inc. In the early 2005, venture capital activity in Ireland increased by 25.7% in comparison with the same period last year, and 70% of the...

  • Sprained Marriage. McLean, Bethany // Fortune;5/15/2000, Vol. 141 Issue 10, p454 

    Focuses on the merger between the biotechnology firm Genzyme Corp. and Biomatrix. Financial implications for Genzyme in the manufacture of the drug Cerezyme for patients with Gaucher's disease; Formation of four separate stocks, including Genzyme General, which did not benefit from the surge of...

  • Kidney drug gets go-ahead in Europe.  // Pharmaceutical Technology Europe;Oct2006, Vol. 18 Issue 10, p14 

    The article reports on the launching of the U.S. based biotech company Genzyme Corp. for the production of the drug Thymoglobulin in Waterford, Ireland. The approval by the U.S. Food & Drug administration allows the company to begin the manufacturing, finishing, packaging and labelling of the...

  • Genzyme acquires Cell Genesys. Niiler, Eric // Nature Biotechnology;Dec99, Vol. 17 Issue 12, p1151 

    Reports on the acquisition of a biotechnology company Cell Genesys Inc. in Foster City, California by another biotechnology company Genzyme Corp. in Cambridge, Massachusetts in October 1999 for 350 million dollars. Benefits of the deal to both the companies; Number of patents gained by Genzyme;...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics